Zinc oxide nanoparticles accelerate the healing of methicillin-resistant Staphylococcus aureus (MRSA)-infected wounds in rabbits
Muhammad Asif , Ayesha Safdar Chaudhry , Ambreen Ashar , Hamad Bin Rashid , Muhammad Hassan Saleem , Hassaan Bin Aslam , Abdul Aziz
Asian Pacific Journal of Tropical Biomedicine ›› 2023, Vol. 13 ›› Issue (11) : 488 -496.
Objective: To synthesize zinc oxide nanoparticles (ZnONPs) and evaluate their antibacterial and wound healing effects against wounds infected with methicillin-resistant Staphylococcus aureus (MRSA). Methods: ZnONPs were prepared by sol-gel method and characterized by X-ray diffraction (XRD) analysis and scanning electron microscopy (SEM). A total of 18 rabbits were divided into three groups: the ZnONPs group, the gentamicin group and the control group. A wound of 3 cm2 was inflicted on each rabbit and contaminated with MRSA inoculum. Treatment was started from the fourth day post-surgery. Wound healing, microbiological analysis, and histopathological analysis were performed to assess the efficacy of ZnONPs ointment. Results: XRD analysis confirmed the hexagonal wurtzite structure of the ZnONPs with an average crystallite size of 29.23 nm. SEM revealed discoid-shaped ZnONPs with a rough surface and an average size of 48.36 nm. Energy-dispersive X-ray analysis confirmed the purity of ZnONPs. Moreover, the particle size ranged from 100-700 nm with a high agglomeration trend. Treatment with ZnONPs promoted MRSA-infected wound healing. In addition, ZnONPs showed a good antibacterial effect as evidenced by a dose-dependent increase in the zone of inhibition. Conclusions: ZnONPs accelerate the healing of MRSA-infected wounds. Therefore, it can be explored for the treatment of MRSA infection.
MRSA / Wound healing / ZnO / Nanoparticles / Ointment
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
/
| 〈 |
|
〉 |